Prestige Wealth Management Group LLC
Position in OTLK — Outlook Therapeutics, Inc.
CIK 1772715
FLEMINGTON, NJ
Position in OTLK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$12
-$85 QoQ
Shares Held
62
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 54 holders
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in OTLK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prestige Wealth Management Group LLC holds $563,805 across 26 Biotechnology names. OTLK ranks #26 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
847 | $378,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
226 | $74,776 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
63 | $48,676 | |
| 4 | INCY |
Incyte Corp
|
132 | $12,423 | |
| 5 | MRNA |
Moderna, Inc.
|
137 | $6,959 | |
| 6 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
107 | $6,708 | |
| 7 | STOK |
Stoke Therapeutics, Inc.
|
200 | $6,512 | |
| 8 | ARQT |
Arcutis Biotherapeutics, Inc.
|
250 | $5,890 |
All Filings in OTLK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12 | 62 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $97 | 62 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $65 | 62 | Shares | Sole | 2026-02-20 | |
| 2025-06-30 | $99 | 62 | Shares | Sole | 2026-02-20 | |
| 2025-03-31 | $75 | 62 | Shares | Sole | 2026-02-20 | |
| 2024-12-31 | $117 | 62 | Shares | Sole | 2026-02-20 | |
| 2024-09-30 | $331 | 62 | Shares | Sole | 2026-02-20 | |
| 2024-06-30 | $457 | 62 | Shares | Sole | 2026-02-20 | |
| 2024-03-31 | $740 | 62 | Shares | Sole | 2024-04-26 | |
| No filing history on record for this holder in this stock. | ||||||